Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs

Clinical Toxicology

Volumn 44, Issue SUPPL. 1, 2006, Pages 5-15

  Borron, Stephen W ^a   Stonerook, Michael ^b   Reid, Frances ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

Antidotes; Cyanides; Hydroxocobalamin

Indexed keywords

ANTIDOTE; CYANIDE; CYANOKIT; HYDROXOCOBALAMIN; POTASSIUM CYANIDE; SODIUM CHLORIDE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYANIDE POISONING; DETERIORATION; DOG; DOSE RESPONSE; DRUG EFFICACY; DYING; EUTHANASIA; FEMALE; MALE; MORTALITY; NEUROTOXICITY; NONHUMAN; OXYGEN BREATHING; SURVIVAL TIME;

ACUTE DISEASE; ANIMALS; ANTIDOTES; BLOOD PRESSURE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HYDROXOCOBALAMIN; LACTIC ACID; MALE; MODELS, ANIMAL; NEUROLOGIC EXAMINATION; POISONING; POTASSIUM CYANIDE; RANDOM ALLOCATION; RESPIRATORY FUNCTION TESTS; SODIUM CHLORIDE;

ANIMALIA; CANIS FAMILIARIS;

EID: 33749015727     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650600811672     Document Type: Article

References (23)

1. Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med 2001; 37:635-641.
2. Baud FJ, Barriot P, Toffis V, Riou B, Vicaut E, Lecarpentier Y, Bourdon R, Astier A, Bismuth C. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991; 325:1761-1766.
3. Eckstein M. Cyanide as a chemical terrorism weapon. JEMS 2004; 29(suppl):22-31.
4. Mégarbane B, Delahaye A, Goldgran-Tolédano D, Baud FJ. Antidotal treatment of cyanide poisoning. J Chin Med Assoc 2003; 66:193-203.
5. Fortin J-L, Ruttimann M, Domanski L, Kowalski JJ. Hydroxocobalamin: treatment for smoke inhalation-associated cyanide poisoning. Meeting the needs of fire victims. JEMS 2004; 29:suppl 18-21.
6. Baud FJ, Borron SW, Mégarbane B, Trout H, Lapostolle F, Vicaut E, Debray M, Bismuth C. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med 2002; 30:2044-2050.
7. Borron SW, Barriot P, Imbert M, Baud FJ. Hydroxocobalamin for empiric treatment of smoke inhalation-associated cyanide poisoning: results of a prospective study in the prehospital setting. Abstract 275. Ann Emerg Med 2005; S77.
8. Fortin J-L, Ruttimann M, Domanski L, Kowalski JJ. Hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Abstract. Prehosp Emerg Care 2006; 10:142.
9. Borron S, Mégarbane B, Baud FJ. Hydroxocobalamin is an effective antidote in severe acute cyanide poisoning in man. Abstract. Int J Toxicol 2004; 23:399-400.
10. Bromley J, Hughes BG, Leong DC, Buckley NA. Life-threatening interaction between complementary medicines: cyanide toxicity following ingestion of amygdalin and vitamin C. Ann Pharmacother 2005; 39:1566-1569.
11. Department of Health and Human Services. Food and Drug Administration. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. FR Doc. 02-13583. May 23, 2002.
12. Ings RM. Interspecies scaling and comparison in drug development and toxicokinetics. Xenobiotica 1990; 20:1201-1231.
13. Chaturvedi AK, Sanders DC, Endecott BR, Ritter RM. Exposures to carbon monoxide, hydrogen cyanide and their mixtures: interrelationship between gas exposure concentration, time to incapacitation, carboxyhemoglobin and blood cyanide in rats. J Appl Toxicol 1995; 15:357-363.
14. Purser DA, Grimshaw P, Berrill KR. Intoxication by cyanide in fires: a study in monkeys using polyacrylonitrile. Arch Environ Health 1984; 39:394-400.
15. de La Coussaye JE, Houeto P, Sandouk P, Levillain P, Sassine A, Riou B. Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol 1994; 6:111-115.
16. Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19:26-32.
17. National Research Council: Institute of Laboratory Animal Resources Commission on Life Sciences. Guide for the care and use of laboratory animals. Washington DC: National Academy Press, 1996.
18. von Landenberg F, Stonerook M, Judge M, Borron SW. Efficacy of hydroxocobalamin in a canine model of cyanide poisoning: a pilot study. Abstract. Clin Tox 2005; 43:692.
19. Rosenthal RE, Bogaert YE, Fiskum G. Delayed therapy of experimental global cerebral ischemia with acetyl-L-carnitine in dogs. Neurosci Lett 2005 18; 378:82-87.
20. Benjamini Y, Hochberg Y. The adaptive control of the false discovery rate in multiple hypotheses testing. J Behav Educ Statist 2000; 25:60-83.
21. Gerth K, Ehring T, Braendle M, Schelling P. Nitric oxide scavenging by hydroxocobalamin accounts for its hemodynamic profile. Clin Tox 2006; 44(S1):31-39.
22. Greenberg SS, Xie J, Zatarain JM, Kapusta DR, Miller MJ. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 1995; 273:257-265.
23. Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. Clin Toxicol 1993; 31:277-294.